IMU 0.00% 5.5¢ imugene limited

Failures by BMS and Roche could leave the door open for Imugene....

  1. 152 Posts.
    lightbulb Created with Sketch. 507
    Failures by BMS and Roche could leave the door open for Imugene. This article is in relation to kidney cancer.

    https://www.fiercepharma.com/pharma/esmo-bristol-myers-roche-fail-postsurgery-kidney-cancer-it-good-news-mercks-keytruda

    w w w.f i e r c e p h a r m a.c o m/pharma/esmo-bristol-myers-roche-fail-postsurgery-kidney-cancer-it-good-news-mercks-keytruda
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
0.000(0.00%)
Mkt cap ! $404.2M
Open High Low Value Volume
5.6¢ 5.7¢ 5.5¢ $379.9K 6.840M

Buyers (Bids)

No. Vol. Price($)
15 1581916 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 680013 6
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.